Atrial Flutter

Mass ECG screening for atrial fibrillation in older adults did not reduce the incidence of stroke or stroke hospitalization, according to the results of two trials presented at the European Society of Cardiology Congress.

PHILADELPHIA — Adults with obesity and atrial fibrillation treated with liraglutide plus risk factor modification had improved outcomes after catheter ablation compared with those prescribed risk factor modification alone.

A dual-chamber leadless pacemaker was successfully implanted in most patients and met its 3-month safety and efficacy performance goals, according to the results of the Aveir DR i2i investigational device exemption trial.

Dronedarone was associated with lower incidence of permanent atrial fibrillation/atrial flutter, more return to permanent sinus rhythm and lower AF/atrial flutter burden vs. placebo, according to a post hoc analysis of the ATHENA trial.

A trial of a gold-tipped contact force-sensing catheter for treatment of patients with atrial flutter met its primary endpoints, researchers reported at AF Symposium.

Compared with stable alcohol intake, a 5-year increase in alcohol consumption is associated with an increased risk for incident atrial fibrillation, according to a study published in European Journal of Preventive Cardiology.

In recognition of National Atrial Fibrillation Awareness Month, Healio and Cardiology Today have aggregated some of the recent updated in AF research and treatment.

Atrial flutter catheter ablation in patients without a history of atrial fibrillation reduced risk for death, stroke, HF and AF compared with medical management, according to an abstract presented at Heart Rhythm 2021.